Sign in
EOCN Stock Price, Chart, Stats & News
Eocene Ltd.
Save
Eocene Ltd. (EOCN) does not currently pay a dividend.
4.00M
Market cap
–
Current P/E
–
Forward P/E
EOCN chart
Price history is unavailable
We don't have enough price data for EOCN to draw a chart yet.
About
Eocene Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company was founded by Allen Baharaff and Tuvia Gilat in 2000 and is headquartered in Tel Aviv, Israel.
Similar securities
Based on sector and market capitalization
Report issue